PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients

Patients with cirrhosis who are treated with a proton pump inhibitor (PPI) face an increased risk of hepatic encephalopathy, and the risk rises in a dose-dependent fashion, a large study from Taiwan has found.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news